Clinical Outcome, Role of BRAFV600E, and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer? (Q42174969)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 27, 2012

Language	Label	Description	Also known as
English	Clinical Outcome, Role of BRAFV600E, and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?	scientific article published on February 27, 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer? (English)

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Clinical Outcome, Role of BRAFV600E, and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer? (English)

1 reference

10.3389/FENDO.2012.00033

https://api.crossref.org/works/10.3389/FENDO.2012.00033

2 January 2025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

clinical endpoint

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

tumor microenvironment

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

papillary thyroid Microcarcinoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

Alfredo Pontecorvi

2

object named as

Alfredo Pontecorvi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

author name string

Carmelo Nucera

1

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22649416

2 January 2025

publication date

27 February 2012

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

full work available at URL

https://www.frontiersin.org/articles/10.3389/fendo.2012.00033/pdf

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

https://europepmc.org/articles/PMC3355963

HyperText Markup Language

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

https://europepmc.org/articles/PMC3355963?pdf=render

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22649416

2 January 2025

Frontiers in Endocrinology

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

33

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

Role of BRAF in thyroid oncogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Multikinase inhibitors: a new option for the treatment of thyroid cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Metastatic Dormancy and Progression in Thyroid Cancer: Targeting Cells in the Metastatic Frontier

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

BRAFV600E and Microenvironment in Thyroid Cancer: A Functional Link to Drive Cancer Progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Targeting BRAFV600E with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

A Phase II Trial of Sorafenib in Metastatic Melanoma with Tissue Correlates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Phase II trial of sorafenib in metastatic thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

BRAF(V600E) mutation and the biology of papillary thyroid cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Clinical features and therapeutic implication of papillary thyroid microcarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Loss of p27 expression through RAS-->BRAF-->MAP kinase-dependent pathway in human thyroid carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

S100A4, a mediator of metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Thyroid microcarcinoma: prevalence, prognosis, and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Papillary thyroid microcarcinoma: clinical study and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Papillary microcarcinoma of the thyroid gland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Thyroid cancer and Graves' disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

26 October 2017

Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

29 May 2018

Frequency of Thyroid Carcinoma in a Recent Series of 539 Consecutive Thyroidectomies for Multinodular Goiter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

29 May 2018

Skull metastasis with brain invasion from thyroid papillary microcarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

29 May 2018

Medullary thyroid cancer and Graves' disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

29 May 2018

Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

29 May 2018

Visually discernible [18F]fluorodeoxyglucose uptake in papillary thyroid microcarcinoma: a potential new risk factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Simultaneous occurrence of medullary and papillary carcinoma of the thyroid gland identified by fine needle aspiration. A case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Clinicopathologic and Immunohistochemical Studies of Papillary Thyroid Microcarcinoma Presenting with Cervical Lymphadenopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Thyroid incidentalomas. Prevalence by palpation and ultrasonography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

17 August 2018

Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably benign thyroid disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

3 November 2018

Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

3 November 2018

Medullary and papillary tumors are frequently associated in the same thyroid gland without evidence of reciprocal influence in their biologic behavior

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355963

3 November 2018

Treatment of micropapillary carcinoma of the thyroid: where do we draw the line?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small papillary thyroid cancers—is BRAF of prognostic value?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence of BRAF V600E in very early stages of papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillary microcarcinoma of the thyroid: how should it be treated?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small carcinomas of the thyroid. A long-term follow-up of 867 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent RET rearrangements in thyroid papillary microcarcinoma detected by interphase fluorescence in situ hybridization

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple localization and lymphatic involvement of papillary micro-carcinoma of the thyroid. Results of total thyroidectomy with bilateral lymph node excision. Apropos of 38 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between cell proliferation activity and morphological characteristics of papillary microcarcinoma in the thyroid of Graves' disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillary microcarcinoma of the thyroid

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillary microcarcinoma of the thyroid gland: analysis of prognostic factors including histological subtype

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in Clinical Presentation, Management and Outcome in 1348 Patients with Differentiated Thyroid Carcinoma: Experience in a Single Institute in Hong Kong, 1960–2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes of patients with differentiated thyroid carcinoma following initial therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of multifocal papillary thyroid carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22649416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FENDO.2012.00033

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42174969&oldid=2294027601"